Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2-Reference-Cited by-同舟云学术

Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2

Published:2019-06 Issue:12 Volume:29 Page:1507-1513
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Wang Wanqi,Diao Yanyan,Li Wenjie,Luo Yating,Yang Tingyuan,Zhao Yuyu,Qi TianTian,Xu Fangling,Ma Xiangyu,Ge Huan,Liang Yingfan,Zhao Zhenjiang,Liang Xin^ORCID,Wang Rui,Zhu Lili,Li Honglin^ORCID,Xu Yufang

Funder

National Key Research and Development Program

National Natural Science Foundation of China

National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program”

Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. Regulation of JAK–STAT signalling in the immune system

2. Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains

3. The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

4. O'SHEA;Kawamura;Proc Natl Acad Sci USA,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Evaluations and Computer-Aided Approaches of Janus Kinases 2 and 3 Inhibitors for Cancer Treatment: A Review;Pharmaceutics;2024-09-04

2. Molecular modeling of novel 2-aminopyridine derivatives as potential JAK2 inhibitors: a rational strategy for promising anticancer agents;Journal of Biomolecular Structure and Dynamics;2024-03-06

3. Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics;MedComm – Oncology;2024-03

4. Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations;Bioorganic Chemistry;2024-02

5. Efficacy of WWQ-131, a highly selective JAK2 inhibitor, in mouse models of myeloproliferative neoplasms;Biomedicine & Pharmacotherapy;2022-12